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Abstract
Background: Cissampelos sympodialis (Menispermaceae), known as “Milona” has a specific verified medicinal use for
the treatment of diarrhea and respiratory tract diseases. This work aims to evaluate the antimotility and antidiarrheal
activity of crude ethanolic extract (EtOHE-Cs), and the total alkaloid fraction (TAF-Cs) obtained from aerial parts of C.
sympodialis.
Methods: Normal intestinal transit and gastric emptying were used to evaluate antimotility activity. Castor oil-induced
diarrhea and castor oil-induced enteropooling were used to evaluate antidiarrheal activity.
Results: The results indicated that EtOHE-Cs has no antimotility activity, but did demonstrate antidiarrheal activity
(at 500 mg/kg), and this activity is related to reduction of intestinal fluid accumulation. The TAF-Cs (at 250 and
500 mg/kg) showed antidiarrheal activity by reducing gastrointestinal motility (gastric emptying and normal
intestinal transit).
Conclusions: The antidiarrheal activity of C. sympodialis can be attributed to the chemical compounds already
isolated and quantified in this species, mainly alkaloids.
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Background
Diarrhea is characterized by an increase in the fre-
quency of bowel movements, abdominal pain, and
bowel discharge of semisolid or watery fecal matter
(three or more times in a day) [1,2]. Control of gastro-
intestinal motility is very complex involving multiple
signals, such as nitric oxide (NO), gastrin, ghrelin, pros-
taglandins, 5-hydroxytryptamine (5-HT), dopamine,
catecholamine, and acetylcholine [3,4]. The main causes
of diarrhea are imbalances in the pathways just men-
tioned, as well as infectious agents, plant toxins, and in-
flammatory problems [5]. Worldwide, the disease
affects around 2.2 million people annually, and those
most affected are children under the age of five years
[6]. Changes in gastric emptying coordination cause not
only poor nutrient digestion and absorption, but also
the development of diseases. Fully 25-40% of patients
with functional dyspepsia report delays in gastric
emptying. The development of duodenal ulcers is often
related to the stimulation of gastric emptying, since
acid content is not completely neutralized in the duo-
denum [7-10].
Medicinal herbs constitute the majority component of
traditional medicines as they are practiced worldwide;
this is due to their economic viability, accessibility, and
ancestral experiences [11]. Thus, for gastrointestinal dis-
orders, (such as diarrhea) researching medicinal herbs
has become very important in developing new therapies.
Cissampelos sympodialis Eichl, belongs to the family
Menispermaceae, and is known as “bindweed”, and in
Brazil as “milona”, “jarrinha”, or “orelha-de-onça”. It is
widely used by Indian tribes, and in folk medicine to
treat various diseases such as diarrhea, diseases of the
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genitourinary tract, and especially respiratory tract dis-
eases such as asthma [12]. The species was selected for
study because of ethno-pharmacological and chemotaxo-
nomic criterion.
Several chemical compounds belonging to the alka-
loids class have been isolated from the specie’s leaves
and roots, as examples the: bisbenzylisoquinolinic (warif-
teine, methylwarifteine, roraimine, and simpodialine);
morphinic (milonine); aporphinic (laurifolin) and oxo-
aporphinic (liriodenine) alkaloids [13,14]. Quality control
studies have shown that both alcoholic fractions of the
leaves (AFLs), and alcoholic fractions of the roots (AFRs)
present alkaloids as their principal compounds, being
warifteine the chemical marker of both AFL and AFR
[15]. Crude ethanolic extract (EtOHE-Cs) was standard-
ized using warifteine and methylwarifteine as markers
that were also found in the total alkaloid fraction (TAF-
Cs) [16]. The aqueous fraction of the EtOHE-Cs has
shown spasmolytic activity on tracheal smooth muscle,
and this activity involving inhibition of phosphodiester-
ase (PDE) and increased levels of cyclic adenosine
monophosphate (cAMP) in guinea pig trachea. Warif-
teine, a bisbenzylisoquinolinic alkaloid obtained from C.
sympodialis also has shown spasmolytic activity by in-
hibition of calcium channels (in the rabbit thoracic
aorta) and activation of potassium channels (in the rat
thoracic aorta) [13, 17, 18]. Thus, considering the studies
cited above and other studies reporting the antidiarrheal
activity of alkaloids [19] probably alkaloids of C. sympo-
dialis can be used in diarrhea therapy. Based on its
popular use and its spasmolytic activity “in vitro”, the
aim of this study was to evaluate the antimotility and
antidiarrheal activities of EtOHE-Cs and TAF-Cs
“in vivo” obtained from aerial parts of C. sympodialis.
Methods
Materials
Metoclopramide hydrochloride 10 mg (SANOFI-
AVENTIS®; Brasil); loperamide hydrochloride 2 mg
(JANSSEN-CILAG®; Brasil); phenol red (VETEC®;
Brasil), charcoal meal (VETEC®; Brasil); and Tween 80
(MERCK®; Germany).
Plant material and extraction
Aerial parts of C. sympodialis were collected from the
garden of the “Centro de Biotecnologia” (CBIOTec/
UFPB) in March 2013, and identified by Dr. Maria de
Fátima Agra (Laboratório de Farmacobotânica - CBIO-
Tec/UFPB). A voucher specimen was deposited in the
“Herbário Lauro Pires Xavier” Herbarium, No. 1456. To
obtain the crude ethanolic extract, dried and pulverized
material from aerial parts of C. sympodialis (4000 g)
were subjected to maceration in 95% ethanol for
72 hours. After extraction, the extractive solution was
concentrated in a rotary evaporator under reduced
pressure at a temperature of 45°C, yielding 300 g of
Figure 1 Effect of oral administration of EtOHE-Cs (a) and TAF-Cs (b) on gastric emptying in mice. (a) ANOVA: F(5,27) = 6.803 (p <0.05) (n = 5–7)
followed by Dunnett’s test (** p <0.01 compared to the 12% Tween solution group). (b) ANOVA: F(5,29) = 40.29 (p <0.05) (n = 5–7) followed by
Dunnett’s test (*** p <0.001 compared to the 12% Tween solution group).
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crude ethanolic extract (EtOHE-Cs). A 100 g aliquot of
the EtOHE-Cs was solubilized in an acid solution (3%
HCl), and filtered with filter paper. The resulting acid
solution was subjected to liquid-liquid partition with
dichloromethane. The dichloromethane layer was dis-
carded, and the acid layer was basified with NH4OH to
pH = 9, with a subsequent extraction into chloroform.
The chloroform phase was filtered, anhydrous sodium
sulfate was added, and the liquid was concentrated in a
rotary evaporator resulting in the TAF-Cs (4.8 g).
Experimental animals
Swiss adult male mice (Mus musculus) weighing between
25-35 g were used for the experiments. The animals
from the “Biotério Professor Thomas George” (UFPB)
were kept at temperatures between 23-25°C, with a 12-
hour light/dark cycle in the animal house. The animals
were fed Labina, and water ad libitum. For the experi-
ments, they were randomly distributed into different ex-
perimental groups. All experiments were started in the
morning, and the experimental procedures were ap-
proved by the “Comitê de Ética em Pesquisa Animal”
(CEPA/CBIOTec/UFPB), and recorded as No. 0705/06,
in accordance with international principles for research
with laboratory animals [20].
Effect of C. sympodialis on gastric emptying
Adult mice, (fasted for 12 h) were randomly divided
into seven groups (n = 7). Mice in the first group re-
ceived 12% Tween 80 solution - vehicle (10 mL/kg), the
second group received metoclopramide (30 mg/kg), and
the other groups received 62.5, 125, 250, and 500 mg/
kg of EtOHE-Cs, or TAF-Cs, the seventh group (zero
time control) received saline solution 0.9%, all by via
oral (v.o.). After 1 h of administration (extract, fraction
and drugs), a suspension of phenol red marker (0.05%)
in carboxymethylcellulose (1.5%) (10 mL/kg) was also
given to each animal (v.o.). The zero time control group
was euthanized (by cervical dislocation) immediately
after the administration of the marker, and the other
groups, after 30 min. The abdominal cavity was opened,
the pylorus and the distal portion of the esophagus
were clipped, the stomach was removed and opened,
and its contents were washed with 7 mL of distilled
water. The gastric contents collected were centrifuged
at 450 g for 15 min, and 1 mL from the supernatant
was mixed with 1 mL of 0.025 M NaOH (pH = 12).
Afterwards, 150 μL of the homogenate was pipetted in
duplicate in a 96 well plate, and a spectrophotometric
reading was made using a 560 nm filter. The results
were expressed as the percentage of gastric emptying
Figure 3 Effect of oral administration of TAF-Cs on normal intestinal transit in mice. ANOVA: F(5,32) = 9.175 (p <0.05) (n = 6–7) followed by
Dunnett’s test (* p < 0.05 ** p <0.01 *** p < 0.001 compared to the 12% Tween solution group).
Fig. 2 Effect of oral administration of EtOHE-Cs on normal intestinal transit in mice. ANOVA: F(5,31) = 9.47 (p <0.05) (n = 5–7) followed by
Dunnett’s test (** p <0.01 compared to the 12% Tween solution group).
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compared to the zero time control using the formula
below [21].
% gastric emptying
¼ 100 – mean absorbance of sample x 100
mean absorbance of the zero time control group
Effect of C. sympodialis on normal intestinal transit
The method previously described by Stickney and
Northup [22] was used with modifications. Adult mice
were fasted for 24 hours, and were randomly divided into
six groups (n = 7). Mice in the first group received 12%
Tween 80 solution - vehicle (10 mL/kg); the second group
received metoclopramide (30 mg/kg) or loperamide
(5 mg/kg); and the other groups received 62.5, 125, 250,
and 500 mg/kg of EtOHE-Cs, or TAF-Cs, respectively, all
by the oral pathway (v.o.). At 1 hour from these adminis-
trations, a suspension of charcoal meal (0.5%) in carboxy-
methylcellulose (0.5%) (10 mL/kg) was given to each
animal (v.o.). After 30 minutes, the animals were eutha-
nized by cervical dislocation to remove the small intestine.
The transit percentage was calculated on the basis of dis-
tance traveled by the charcoal meal as divided by the total
length of the intestine, using the formula below.
% transit ¼ distance traveled by charcoal meal
total length of the intestine
x 100
Effect of C. sympodialis on castor oil-induced diarrhea
For the evaluation of antidiarrheal activity was used as a
basis the methodology described by Awouters and col-
laborators [23] with some local modifications. Adult
mice were fasted for 12 h and were randomly divided
into six groups (n = 5–8). Mice in the first group re-
ceived 12% Tween 80 solution - vehicle (10 mL/kg), the
second group received loperamide (5 mg/kg), and the
other groups received 62.5, 125, 250, and 500 mg/kg of
EtOHE-Cs, or TAF-Cs, respectively, all via oral (v.o.). At
1 hour from these administrations, castor oil was given
to each animal (v.o.) 10 mL/kg. Following the adminis-
tration of castor oil, the animals were placed in separates
cages containing transparent blotting papers for observa-
tion of the total number of feces, and their quantifica-
tion (liquid, semi-solid, and solid) during 4 h. After this,
all the animals were euthanized by cervical dislocation.
The following parameters were monitored: evacuation
classification – 1 (normal stool), 2 (semi-solid stool),
and 3 (watery stool) and evacuation index (EI), expressed
according to the formula:
EI ¼ 1 no: of type 1 stoolsð Þ þ 2
 no: of type 2 stoolsð Þ þ 3
 no: of type 3 stoolsð Þ
Effect of C. sympodialis on castor oil-induced
enteropooling
Animals (adult male mice) were fasted for 12 hours and
were randomly divided into three groups (n = 7). Mice in
the first group received 12% Tween solution 80 - vehicle
(10 mL/kg), the second group received loperamide
(5 mg/kg), and the third group received 500 mg/kg of
EtOHE-Cs, (the only dose that showed antidiarrheal ac-
tivity), all by oral pathway (v.o.). At 1 h from the admin-
istrations, the animals were euthanized by cervical
dislocation, laparotimized, and then the pyloric and cae-
cal ends of the small intestine were tied and the intes-
tines were removed. The content of each intestine was
measured in a graduated measuring cylinder, and the
volume was noted according to Ezeja and Anaga [24].
Statistical analysis
The parametric data were expressed as the mean ±
standard deviation (SD) and non-parametric data were
expressed as median (minimum value – maximum
Table 1 Effect of oral administration of EtOHE-Cs, and





12% Tween 80 solution - 13.0 (12.0 - 18.0)
Loperamide 5 0.0 (0.0 - 1.0)**
EtOHE-Cs 62.5 12.0 (7.0 - 14.0)
EtOHE-Cs 125 13 (9.0 - 19.0)
EtOHE-Cs 250 11.5 (8.0 - 17.0)
EtOHE-Cs 500 4.0 (2.0 - 5.0)*
Data are presented as median (minimum value – maximum value). Kruskal-
Wallis test followed by Dunn’s multiple comparison test (* p <0.05, ** p <0.005
compared to the 12% Tween solution group). The EtOHE-Cs reduced evacuation
index (500 mg/kg) compared to control group (12% Tween 80 solution).
Table 2 Effect of oral administration of TAF-Cs, and
loperamide on castor oil induced diarrhea in mice
Treatment (v.o.) Dose (mg/kg) Evacuation Index (EI)
12% Tween 80 solution - 15.0 (10.0 - 23.0)
Loperamide 5 0.0 (0.9 - 2.0)***
TAF-Cs 62.5 13.5 (6.0 - 16.0)
TAF-Cs 125 6.0 (4.0 - 8.0)
TAF-Cs 250 1.0 (0.0 - 5.0)**
TAF-Cs 500 1.0 (0.0 - 2.0)**
Data are presented as median (minimum value – maximum value). Kruskal-Wallis
test followed by Dunn’s multiple comparison test (** p <0.05, *** p <0.001
compared to the 12% Tween solution group). The TAF-Cs reduced evacuation
index (250 and 500 mg/kg) compared to control group (12% Tween 80 solution).
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value). This data was subjected to variance analysis
(ANOVA), followed by a Dunnett’s test (parametric) or
Kruskal-Wallis test followed by Dunn’s multiple com-
parison test (non-parametric). The minimum level of
significance was p < 0.05 in all analyses. For the data pro-
cessing, INSAT (GraphPad Software© Inc., San Diego,
CA, USA) software was used.
Results and discussion
Effect of C. sympodialis on gastrointestinal motility:
normal intestinal transit and gastric emptying
The antimotility activity of EtOHE-Cs and TAF-Cs was
investigated by measuring gastric emptying, and normal
intestinal transit in mice. Earlier studies have reported
that antimotility and antidiarrheal properties of medi-
cinal plants are due to tannins, alkaloids, saponins, and
sterols [25]. Normal intestinal transit and gastric empty-
ing were not altered for any dose (62.5, 125, 250 and
500 mg/kg) evaluated for EtOHE-Cs, however TAF-Cs
(at 250 and 500 mg/kg) reduced gastric emptying and
normal intestinal transit, as expressed in Figures 1a, 1b,
2 and 3. The results suggest that C. sympodialis alkaloids
affect gastrointestinal motility, and are likely to present
spasmolytic activity “in vivo”. Though showing antimoti-
lity activity, we commenced investigations of anti-
diarrheal activity, because diarrhea is not only caused by
motility deregulation. It is also caused by microorganism
infections, hyper secretion of intestinal fluids, and in-
flammatory bowel disease [26].
Effect of C. sympodialis on castor oil-induced diarrhea and
enteropooling
Diarrhea is a disease that has many clinical signs such as
hyper-propulsive motility of gastrointestinal tract, and
hyper-secretion throughout the intestinal mucosa. Ani-
mal models are commonly used to induce experimental
diarrhea [26, 27], and to study a plants’ mechanisms of
action and active principles.
Castor oil, prostaglandin E2 (PGE2), and heat-labile en-
terotoxin are commonly used to induce diarrhea in
animals. The induction of diarrhea by castor oil is recom-
mended for study of the anti-secretory and antimotility
potential of medicinal plants. “Castor oil diarrhea” is due
to its active metabolite, ricinoleic acid that is released by
the action of intestinal lipases [28].
The liberation of ricinoleic acid results in irritation
and inflammation of the intestinal mucosa, and is associ-
ated with the release of nitric oxide, prostaglandin, and
other autacoids [28, 29]. The enteropooling induced by
castor oil, probably occurs through stimulation of cyclic
AMP/GMP production, and phosphorylation of cystic fi-
brosis transmembrane conductance regulators (CFTRs).
This consequently leads to intestinal motility stimulation
and to increased secretion of fluids and electrolytes
(mainly Cl− and Na+) [30,31].
In castor oil induced-diarrheic animals, the EtOHE-Cs
in its highest dose (500 mg/kg) significantly reduced the
evacuation index as can be seen in Table 1, and TAF-Cs
showed similar antidiarrheal effects at doses of 250 and
500 mg/kg, as can be seen in Table 2.
The EtOHE-Cs does not have antimotility activity. Due
to this, in another step we investigated if the extract had
intestinal anti-secretory activity. For the enteropooling
study, the EtOHE-Cs (at 500 mg/kg) significantly reduced
the intraluminal fluid volumes of the intestinal contents
(Figure 4), suggesting that the EtOHE-Cs antidiarrheal ac-
tivity involves the reabsorption of water and electrolytes
(such as Na+), and probably, the involvement of prosta-
glandins [28].
Conclusions
The antidiarrheal activity of C. sympodialis can be attrib-
uted to chemical compounds already isolated and quan-
tified in this species, such as flavonoids and principally
the alkaloids warifteine and methylwarifteine [32]. These
compounds are known to inhibit autacoid and prosta-
glandin release [33]. Inhibition of prostaglandin E2
Figure 4 Effect of oral administration of EtOHE-Cs on castor oil induced enteropooling in mice. ANOVA: F(2,18) = 18.93 (p <0.05) (n = 7)
followed by Dunnett’s test (*** p <0.001 compared to the 12% Tween solution group).
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(PGE2) is known to reduce secretory response in the in-
testine, and to inhibit gastrointestinal motility [34].
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